Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
Program 1 of 2.
Scroll down to see them all.
 

Takeda Oncology Here2Assist

This program provides brand name medications at no or low cost

Provided by: Takeda Pharmaceutical

PO Box 4280
Gaithersburg, MD 20885-4280

TEL: 844-817-6468


FAX: 844-269-3038
Languages Spoken:

English, Others By Translation Service

Program Website

 

Program Applications and Forms

Takeda Oncology Here2Assist Patient Assistance Program Application

Takeda Oncology Here2Assist Patient Assistance Program Application (Spanish)

Takeda Oncology Here2Assist Enrollment Form

Takeda Oncology Here2Assist Enrollment Form (Spanish)

Takeda Oncology Here2Assist RapidStart Request Form (Alunbrig)

Takeda Oncology Here2Assist RapidStart Request Form (Exkivity)

Takeda Oncology Here2Assist RapidStart Request Form (Iclusig)

Takeda Oncology Here2Assist RapidStart Request Form (Ninlaro)

Takeda Expands Assistance During COVID-19 Crisis Information Letter

 

Medications

  • mobocertinib capsule (Exkivity) Capsule
 

Eligibility Requirements   

Insurance Status Contact program for details.
Those with Part D Eligible? No
Income Not disclosed
Diagnosis/Medical Criteria Medically appropriate condition/diagnosis
US Residency Required? Must be residing in the US or Puerto Rico
   

Application

Obtaining Call or download
Receiving Faxed, emailed or downloaded from website
Returning *See Additional Information section below
Doctor's Action Complete section, sign, attach required documents
Applicant's Action Complete section, sign, attach required documents
Decision Communicated Doctor notified
Decision Timeframe 2 business days, once application process is complete
   

Medication

Amount/Supply Up to 1 month supply
Sent To Patient's home, unless otherwise noted
Delivery Time Not specified
Refill Process Company contacts patient or doctor to arrange
Limit One year
Re-application Maximum is one year
   

Additional Information

Co-payment assistance, and patient assistance programs are available for eligible patients.

Updated April 18, 2022


Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
Program 2 of 2.
 

Patient Access Network Foundation (PAN)

This is a copay assistance program

Provided by: Patient Access Network Foundation


TEL: 866-316-7263


FAX: 866-316-7261
Languages Spoken:

English, Spanish, Others By Translation Service

Program Website

 

Program Applications and Forms

Patient Access Network Foundation (PAN) Application: Contact program

 

Medications

  • mobocertinib capsule (Exkivity) Capsule
 

Eligibility Requirements   

Insurance Status *See Additional Information section below
Those with Part D Eligible? Determined case by case
Income Between 400-500% of FPL
Diagnosis/Medical Criteria FDA Approved Diagnosis - See Program Website for Details
US Residency Required? Must reside and receive treatment in US
   

Application

Obtaining Call or complete online
Receiving Complete online or by phone
Returning Complete online or by phone
Doctor's Action Will be discussed with patient and Doctor after request is received
Applicant's Action Call for information or inform doctor that he/she is in need
Decision Communicated Patient and Doctor notified in writing
Decision Timeframe Within 48 hours
   

Medication

Amount/Supply Not applicable
Sent To Patient sent card to be used at pharmacy
Delivery Time Once approved; shipped same day
Refill Process Patient presents voucher/card to pharmacy for each refill
Limit None
Re-application New application every 12 months
   

Additional Information

*Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.

Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Updated April 25, 2022